Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Vincent JP, Mazella J, Kitabgi P (1999) Neurotensin and neurotensin receptors
After reconstitution, keep solutions refrigerated at 4C and use within manufacturer-recommended timeframes to maintain full compound integrity
Spatial omics A suite of emerging spatial omics technologies is revolutionizing our understanding of tumor spatial heterogeneity and its relationship with acquired therapeutic resistance (Fig
This meant that the visceral discomfort due to UC was significantly reduced in the Si-DSS group compared with that in the Con-DSS group